Among the top 5 candidate genes (UBE2C, ASF1B, FOXM1, HJURP, and KIF18B), UBE2C was the most frequently associated with poor prognosis in publicly available clinical datasets from diverse cancer types, including metastatic melanoma (Figure 1E). This evidence concerns the gene UBE2C and metastatic melanoma.